Bert Vogelstein

BERT VOGELSTEIN, the Clayton Professor of Oncology and a Howard Hughes Investigator, was the first to elucidate the molecular basis of a common human cancer. Dr. Bert Vogelstein attended the University of Pennsylvania, where he graduated with distinction in mathematics. He obtained his medical degree at the Johns Hopkins University School of Medicine and performed his residency in pediatrics at the Johns Hopkins Hospital. Following his clinical training, Dr. Vogelstein completed a post-doctoral fellowship at the National Cancer Institute, focusing on the development of new approaches to study human cancers. He is currently the Co-Director of the Ludwig Center for Cancer Genetics & Therapeutics at the Johns Hopkins Kimmel Cancer Center, a Lustgarten Foundation Distinguished Scholar, and an Investigator of the Howard Hughes Medical Institute.

Dr. Vogelstein’s current research focuses on the genetic basis of human cancers and the use of this knowledge to improve diagnosis and management of patients with these diseases. He is a member of the American Academy of Arts & Sciences, the National Academy of Sciences, the American Philosophical Society, the National Academy of Medicine and the European Molecular Biology Organization (EMBO). His advisory roles have included Chairmanships of the National Research Council Committee on the Biological and Biomedical Applications of Stem Cell Research and the Board of Scientific Counselors of the National Human Genome Research Institute.